0001567619-19-003291.txt : 20190212 0001567619-19-003291.hdr.sgml : 20190212 20190212164118 ACCESSION NUMBER: 0001567619-19-003291 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190212 DATE AS OF CHANGE: 20190212 EFFECTIVENESS DATE: 20190212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 19591456 BUSINESS ADDRESS: STREET 1: 530 FIFTH AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 530 FIFTH AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001728001 XXXXXXXX 12-31-2018 12-31-2018 Athyrium Capital Management, LP

530 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10036

13F HOLDINGS REPORT 028-18509 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 02-12-2019 0 3 103804 false INFORMATION TABLE 2 form13fInfoTable.xml AEGERION PHARMACEUTICALS INC NOTE 2.000% 8/1 00767EAB8 89214 117737000 PRN SOLE 0 0 117737000 PTC THERAPEUTICS INC NOTE 3.000% 8/1 69366JAB7 8071 8067000 PRN SOLE 0 0 8067000 KALA PHARMACEUTICALS INC COM 483119103 6520 1333333 SH SOLE 1333333 0 0